Glioblastoma Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2024 (Updated)

DelveInsight's, "Glioblastoma Pipeline Insight 2024" report provides comprehensive insights about 195+ companies and 210+ pipeline drugs in the Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioblastoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Glioblastoma Pipeline Report
• DelveInsight's Glioblastoma pipeline report depicts a robust space with 195+ active players working to develop 210+ pipeline therapies for Glioblastoma treatment.
• The leading companies working in the Glioblastoma Market include Denovo BioPharma, Pfizer, Vigeo Therapeutics, Celldex Therapeutics, Debiopharm, Prelude Therapeutics, AiVita Biomedical, Ascletis Pharma, Kintara Therapeutics, Bayer AG, Kazia Therapeutics, GlaxoSmithKline, Candel Therapeutics, Symphogen A/S, Sanofi, Oblato, Jiangsu Hengrui Medicine, BPGbio, Inc., Alaunos Therapeutics, Eli Lilly and Company, Actuate Therapeutics, Oncotelic Therapeutics, The Menarini Group, SonALAsense, Novartis, Allarity Therapeutics, PharmAbcine, I-Mab Biopharma Co. Ltd., Aadi Bioscience Inc., Matrix Biomed, Photonamic GmbH & Co. KG, Lixte, Black Diamond Therapeutics, Tmunity Therapeutics, SOM Biotech, Moleculin, Xynomic Pharmaceuticals, OncoSynergy, and others.
• Promising Glioblastoma Pipeline Therapies in the various stages of development include PLX3397, Temozolomide, VXM01, Avelumab, Cilengitide, ACT001, and others.
• September 2023: Laminar Pharmaceuticals announced a study of Phase 2 & 3 Clinical trials for LAM561 and TMZ. The proposed Phase IIB/III randomized, double-blind, placebo-controlled trial in subjects with newly diagnosed primary glioblastoma multiforme (ndGBM) aims to compare the efficacy and safety of LAM561 versus placebo, given with standard of care (SoC) therapy of radiation therapy plus temozolomide (TMZ), followed by an adjuvant treatment of 6 month period of TMZ and then LAM561 or placebo in monotherapy.
• September 2023: Cantex Pharmaceuticals announced a study of Phase 1 & 2 Clinical trials for Azeliragon 5 mg. This is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients with newly diagnosed glioblastoma receiving concurrent radiation and temozolomide.

Request a sample and discover the recent advances in Glioblastoma Treatment Drugs @ Glioblastoma Pipeline Report- https://www.delveinsight.com/sample-request/glioblastoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

In the Glioblastoma pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, Glioblastoma clinical trials studies, NDA approvals (if any), and product development activities comprising the technology, Glioblastoma collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Glioblastoma Overview
Glioblastoma Multiforme is the most frequently occurring type of primary tumors of the central nervous system (CNS) mostly in adults, and its poor prognosis has not been significantly improved despite the fact that the innovative diagnostic strategies and new therapies have been developed. Somatic evolution promotes the progression of cancer in which the genome of the cancer cell is being deviated from that of the healthy cell due the accumulation of mutations.

Find out more about Glioblastoma Therapeutics Assessment @ Glioblastoma Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/glioblastoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Glioblastoma Emerging Drugs Profile
• Enzastaurin: Denovo BioPharma
• Tofacitinib: Pfizer
• VT1021: Vigeo Therapeutics
• Varlilumab: Celldex Therapeutics
• Debio 0123: Debiopharm
• PRT3645: Prelude Therapeutics

Glioblastoma Pipeline Therapeutics Assessment
There are approx. 195+ key companies which are developing the Glioblastoma therapies. The Glioblastoma companies which have their Glioblastoma drug candidates in the most advanced stage, i.e. phase III include, Denovo BioPharma.

Learn more about the emerging Glioblastoma Pipeline Therapies @ Glioblastoma Clinical Trials Assessment- https://www.delveinsight.com/sample-request/glioblastoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Glioblastoma Pipeline Report
• Coverage- Global
• Glioblastoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Glioblastoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Glioblastoma Companies- Denovo BioPharma, Pfizer, Vigeo Therapeutics, Celldex Therapeutics, Debiopharm, Prelude Therapeutics, AiVita Biomedical, Ascletis Pharma, Kintara Therapeutics, Bayer AG, Kazia Therapeutics, GlaxoSmithKline, Candel Therapeutics, Symphogen A/S, Sanofi, Oblato, Jiangsu Hengrui Medicine, BPGbio, Inc., Alaunos Therapeutics, Eli Lilly and Company, Actuate Therapeutics, Oncotelic Therapeutics, The Menarini Group, SonALAsense, Novartis, Allarity Therapeutics, PharmAbcine, I-Mab Biopharma Co. Ltd., Aadi Bioscience Inc., Matrix Biomed, Photonamic GmbH & Co. KG, Lixte, Black Diamond Therapeutics, Tmunity Therapeutics, SOM Biotech, Moleculin, Xynomic Pharmaceuticals, OncoSynergy, and others.
• Glioblastoma Pipeline Therapies- PLX3397, Temozolomide, VXM01, Avelumab, Cilengitide, ACT001, and others.

Dive deep into rich insights for new drugs for Glioblastoma Treatment, Visit @ Glioblastoma Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/glioblastoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Glioblastoma: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Glioblastoma- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Enzastaurin: Denovo BioPharma
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Varlilumab: Celldex Therapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. PRT3645: Prelude Therapeutics
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. ELC-401: Elicera Therapeutics
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Glioblastoma Key Companies
21. Glioblastoma Key Products
22. Glioblastoma- Unmet Needs
23. Glioblastoma- Market Drivers and Barriers
24. Glioblastoma- Future Perspectives and Conclusion
25. Glioblastoma Analyst Views
26. Glioblastoma Key Companies
27. Appendix

For further information on the Glioblastoma Pipeline therapeutics, reach out to Glioblastoma Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/glioblastoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

List of Important Links

https://advicehonest.mn.co/posts/51771873
https://myparea.mn.co/posts/51772057
https://friendsgroup.mn.co/posts/51772171
https://thinktrain.mn.co/posts/51772402
https://sokomtaani.mn.co/posts/51772489
https://lighttimeandsound.mn.co/posts/51772991
https://pepins.mn.co/posts/51773122
https://pologics.mn.co/posts/51773247
https://rdd-rapter-gameing.mn.co/posts/exploring-the-uveitis-market-trends-treatment-and-future-prospects
https://machineintelligence.mn.co/posts/understanding-the-dynamics-of-the-uveitis-market-current-trends-and-future-prospects
https://freeline.mn.co/posts/51773807
https://creepypasta-club.mn.co/posts/51773889
https://germandennydones.levitra-wiki.com/578530/understanding_the_obstructive_sleep_apnea_market_trends_and_innovations
https://germandennydones.wikiap.com/578762/obstructive_sleep_apnea_market_outlook_insights_and_forecast
https://germandennydones.magicianwiki.com/468393/obstructive_sleep_apnea_market_trends_report
https://germandennydones.wikigiogio.com/576995/obstructive_sleep_apnea_market_forecast_promising_growth_on_the_horizon
https://germandennydones.buscawiki.com/581631/obstructive_sleep_apnea_market_size_and_outlook_report
https://germandennydones.national-wiki.com/571216/obstructive_sleep_apnea_market_size_and_growth_trends
https://germandennydones.wikibyby.com/578358/the_growing_market_for_obstructive_sleep_apnea_understanding_trends_and_opportunities
https://germandennydones.wikigop.com/473790/obstructive_sleep_apnea_market_outlook_insights_and_forecast
https://germandennydones.wikilentillas.com/579853/obstructive_sleep_apnea_market_trends_rising_demand_and_innovative_solutions
https://germandennydones.wikikarts.com/577254/obstructive_sleep_apnea_market_forecast_a_promising_outlook
https://germandennydones.wikikali.com/473261/understanding_the_dynamics_of_the_obstructive_sleep_apnea_market
https://germandennydones.blogerus.com/48168367/understanding-the-growing-market-of-obstructive-sleep-apnea-trends-and-opportunities
https://germandennydones.educationalimpactblog.com/47820848/obstructive-sleep-apnea-market-outlook-insights-and-forecast
https://germandennydones.blogofoto.com/56666360/obstructive-sleep-apnea-market-seeing-strong-growth
https://germandennydones.uzblog.net/obstructive-sleep-apnea-market-forecast-a-promising-future-for-diagnosis-and-treatment-39847385
https://germandennydones.timeblog.net/61328840/understanding-the-obstructive-sleep-apnea-market-trends-treatments-and-future-outlook
https://germandennydones.tdlwiki.com/568134/exploring_the_obstructive_sleep_apnea_market_trends_challenges_and_innovations
https://germandennydones.nytechwiki.com/9636224/obstructive_sleep_apnea_market_outlook_report
https://germandennydones.hamachiwiki.com/582879/obstructive_sleep_apnea_market_witnessing_significant_growth_amidst_rising_awareness
https://germandennydones.blgwiki.com/576825/obstructive_sleep_apnea_market_forecast_growing_awareness_and_technological_advancements_drive_promising_growth
https://germandennydones.westexwiki.com/572553/obstructive_sleep_apnea_market_outlook_report
https://germandennydones.salesmanwiki.com/8709281/exploring_the_dynamics_of_the_atopic_dermatitis_market_a_comprehensive_insight_by_delveinsight
https://germandennydones.wikidank.com/563894/atopic_dermatitis_market_emerging_therapies_and_promising_growth_prospects
https://germandennydones.celticwiki.com/579052/atopic_dermatitis_market_forecast_a_comprehensive_analysis_by_delveinsight
https://germandennydones.nico-wiki.com/564772/article_under_review
https://germandennydones.link4blogs.com/47773304/atopic-dermatitis-epidemiology-a-comprehensive-review
https://www.longisland.com/articles/a/dashboarddetail/?aid=85681
https://germandennydones.blue-blogs.com/31720862/exploring-the-dynamics-of-the-atopic-dermatitis-market-insights-by-delveinsight
https://germandennydones99.popup-blog.com/25459293/manual-article-review-is-required-for-this-article
https://germandennydones.blogzag.com/70190843/exploring-the-atopic-dermatitis-market-insights-by-delveinsight
https://germandennydones.aioblogs.com/79380412/atopic-dermatitis-market-forecast-a-comprehensive-analysis-by-delveinsight
https://bitspower.com/support/user/germandennydones
https://www.rubylathon.com/profile/ybhardwaj/profile
https://www.dungeondelights.com/profile/ybhardwaj/profile
https://www.seereadshare.com/exploring-the-atopic-dermatitis-market-insights-by-delveinsight/
https://mel-assessment.com/members/germandennydones/activity/1432418/
https://intuitive-schooling.mn.co/posts/52010558
https://network-84066.mn.co/posts/52010704
https://network-7596718.mn.co/posts/52011059
https://scratchgram-2nd-instagram2.mn.co/posts/atopic-dermatitis-market-forecast-a-comprehensive-analysis-by-delveinsight
https://amy-anisas-community.mn.co/posts/52012754
https://justchatting.mn.co/posts/52012853
https://childtalk.mn.co/posts/52019555
https://mntrone.mn.co/posts/52019661
https://kemono-friends-united.mn.co/posts/52019913
https://network-89730.mn.co/posts/52019972
https://fromstarttofinish.mn.co/posts/52392712
https://network-1061063.mn.co/posts/52393073
https://veganxyz.mn.co/posts/52393126
https://spurstartup.mn.co/posts/52393338
https://hplustraining.mn.co/posts/52393458
https://would.mn.co/posts/52393827
https://swadeshi.mn.co/posts/52394053
https://landofbands.mn.co/posts/atopic-dermatitis-market-outlook-insights-by-delveinsight
https://stemfemmes.mn.co/posts/atopic-dermatitis-market-forecast-insights-and-trends
https://investment-dynamicgr2021.mn.co/members/16644536
https://hubvin.mn.co/posts/52394813
https://quantummemoir.mn.co/members/21285995
https://bitcoinov.mn.co/members/22774771
https://germandennydones.csublogs.com/31590275/atopic-dermatitis-market-outlook-insights-by-delveinsight
https://transgirlsays.mn.co/posts/52395381
https://germandennydones.develop-blog.com/profile
https://germandennydones.is-blog.com/profile
https://germandennydones.livebloggs.com/profile
https://germandennydones.loginblogin.com/profile
https://germandennydones.mdkblog.com/profile
https://germandennydones.thenerdsblog.com/profile
https://germandennydones.newbigblog.com/profile
https://germandennydones.theobloggers.com/profile
https://germandennydones.vblogetin.com/profile
https://germandennydones.worldblogged.com/profile
https://germandennydones.yomoblog.com/profile
https://germandennydones.digiblogbox.com/51347845/exploring-the-atopic-dermatitis-market-outlook-insights-by-delveinsight
https://freedomlifestyle.mn.co/posts/52397211
https://profitfirst.mn.co/posts/52397363
https://chineseintheus.mn.co/posts/understanding-the-sepsis-market-trends-challenges-and-opportunities
https://network-6342899.mn.co/posts/52507131
https://kbb-hub.mn.co/posts/52507297
https://connecting-within.mn.co/posts/52507568
https://interface.mn.co/posts/52507782
https://spy-co.mn.co/posts/understanding-the-dynamics-of-the-sepsis-market-trends-challenges-and-opportunities
https://network-45056.mn.co/posts/52508118
https://bridesquad-glam.mn.co/posts/52508228
https://primal-dread.mn.co/posts/unveiling-the-dynamics-of-the-sepsis-market-a-comprehensive-analysis
https://networksbusiness.mn.co/posts/52509513
https://mycaipi.mn.co/posts/52510209
https://network-3352.mn.co/posts/52510330
https://resilientcampus.mn.co/posts/52511234
https://nishweb-members.mn.co/posts/52511407
https://pvd-psycho.mn.co/posts/52511673
https://network-7596718.mn.co/posts/52511830
https://newshour.mn.co/members/22811979
https://kissanime.mn.co/posts/52512184
https://vibe2.mn.co/posts/52516062
https://aspiringexecutives.mn.co/posts/52516168
https://network-44050.mn.co/posts/52516267
https://vividgram.mn.co/posts/52516608
https://memberstayshop.mn.co/members/22813167
https://maggie-dong.mn.co/posts/52516846

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

This release was published on openPR.